Manual Therapy Treatment for Myofascial Pain

This study has been completed.
Sponsor:
Information provided by:
Federal University of São Paulo
ClinicalTrials.gov Identifier:
NCT01381380
First received: June 23, 2011
Last updated: June 24, 2011
Last verified: November 2007
  Purpose

This study is a pain intensity evaluation in patients with myofascial pain submitted kinesitherapy after trigger point injection.


Condition Intervention
Myofascial Pain Syndromes
Procedure: Manual therapy

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Effect of Manual Therapy After Trigger Point Injection for Myofascial Pain Syndrome

Resource links provided by NLM:


Further study details as provided by Federal University of São Paulo:

Primary Outcome Measures:
  • Pain intensity [ Time Frame: 8 weeks ] [ Designated as safety issue: No ]
    once a week for 8 weeks (T1 to T8)


Enrollment: 30
Study Start Date: November 2006
Study Completion Date: December 2009
Primary Completion Date: November 2007 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
single-arm studies
Manual therapy for one group
Procedure: Manual therapy
Manual therapy, once a week for 8 weeks
Other Names:
  • massage
  • finger pressure
  • myofascial release
  • mobilization

Detailed Description:

Randomized prospective study conducted on 30 patients of both genders ranging in age from 18 to 60 years, with neck and shoulder girdle Myofascial Pain Syndrome (MFS), with a duration of ≥ 4 months and pain intensity ≥ 4.

Trigger point injection of 1 mL 0.25% bupivacaine at each point, once a week for 8 weeks (T1 to T8).

Group 1: kinesiotherapy once a week for 8 weeks Group 2: not submitted to kinesiotherapy Evaluation of pain intensity on the first assessment (T0) and after 1, 2, 3, 4, 5, 6, 7, 8, and 9 weeks

  Eligibility

Ages Eligible for Study:   18 Years to 60 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • myofascial pain of neck and shoulder girdle, lasting ≥ 4 months, pain intensity ≥ 4.

Exclusion Criteria:

  • arrhythmia
  • heart block
  • coagulopathy
  • cognitive alterations and infection at the site
  • patients using anticoagulants, and pregnant women
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01381380

Locations
Brazil
Setor de Dor
São Paulo, Brazil, 04023-062
Sponsors and Collaborators
Federal University of São Paulo
Investigators
Study Director: Rioko K Sakata, PhD Universidade Federal de São Paulo
  More Information

No publications provided

Responsible Party: Rioko Kimiko Sakata, Universidade Federal de São Paulo
ClinicalTrials.gov Identifier: NCT01381380     History of Changes
Other Study ID Numbers: 1276
Study First Received: June 23, 2011
Last Updated: June 24, 2011
Health Authority: Brazil: National Committee of Ethics in Research

Keywords provided by Federal University of São Paulo:
myofascial pain
trigger point injection
manual therapy

Additional relevant MeSH terms:
Syndrome
Myofascial Pain Syndromes
Fibromyalgia
Disease
Pathologic Processes
Muscular Diseases
Musculoskeletal Diseases
Rheumatic Diseases
Neuromuscular Diseases
Nervous System Diseases

ClinicalTrials.gov processed this record on September 18, 2014